RedHill Biopharma reported $5.51M in Operating Expenses for its fiscal quarter ending in June of 2024.





Operating Expenses Change Date
Cara Therapeutics USD 7.05M 1.11M Mar/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.19M 96K Mar/2026
Cronos Group USD 45.4M 1.26M Jun/2026
RedHill Biopharma USD 5.51M 1.08M Jun/2024